Snam Posts Higher 1st Half Net Profit, Revenue Despite Complex Environment
By Andrea Figueras
Snam on Thursday reported higher first-half net profit and revenue, and confirmed its guidance for the full year.
The Italian gas grid operator posted net profit of 698 million euros ($773.8 million) compared with EUR686 million in the year-earlier period, on revenue that stood at EUR2.09 billion, up from EUR1.68 billion. Operating income rose to EUR758 million from EUR707 million.
Snam's 2023 performance is likely to be hit by higher interest rates and a slowdown in natural gas demand in Italy due to milder weather conditions, demand containment measures and the decline in thermal generation, which reflects an increase in electricity imports and hydroelectric generation, the company said.
Snam confirmed its full-year guidance and sees adjusted net profit around EUR1.1 billion. It also aims to invest EUR2.1 billion, 10% more than in 2022.
For the second half, it expects a further decrease in gas flows from Russia to Europe from the decline already seen in 2022, Snam said.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
July 27, 2023 10:20 ET (14:20 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
What’s Happening In the Markets This Week
-
What Does Nvidia’s Stock Split Mean for Investors?
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
The Most Attractive Investment Opportunities in Oil & Gas
-
Apple: Generative AI Strategy Should Drive Sales and Upgrades
-
2 Undervalued Stocks That Just Raised Dividends
-
2 Popular Stocks That Top Managers Are Selling
-
The Best REITs to Buy
-
Nio Earnings: Revenue and Loss Largely In Line, but Vehicle Margin Missed Amid Price Competition
-
The Best Biotech Stocks to Buy
-
After Earnings, Is Marvell Stock a Buy, a Sell, or Fairly Valued?